Dr. Upinder Singh
SOMG News:
An estimated 7.7 million to 23 million Americans have developed Long-COVID after being infected with the virus, according to The Department of Health and Human Services (HHS).
Long COVID is a condition that occurs when patients still have symptoms at least four weeks after they have cleared the infection. In some cases, symptoms may be experienced for months or years.
Dr. Upinder Singh, a professor of microbiology and immunology and an infectious disease expert, will be the Dr. E. Arthur Dreskin Distinguished Endowed Lecture speaker at the USC School of Medicine Greenville (SOMG) Sept. 21 and online.
Dr. Singh will summarize her research into Long-COVID — focusing on the first observations of chronic sequelae of infection early in the pandemic and the subsequent development of a local clinical program to treat patients with Long-COVID – the first of its kind.
The Dr. Arthur E. Dreskin Distinguished Lecture will be held 5:30-6:30 p.m., Thursday, Sept. 21, is open to the public and will be live streamed online. For more information and to see the live stream link visit: https://qrco.de/USCSOMG_DRESKIN
Dr. Singh will also outline the NIH RECOVER program, a national program to study and define Long-COVID. She will discuss Stanford University’s approach to find treatments for Long-COVID and describe the first global trial of the use of an antiviral (Paxlovid) in its treatment. Dr. Singh will present the rationale, study design and lessons learned to date.
“We are proud to welcome Dr. Singh to the USC School of Medicine Greenville to speak about Long-COVID, an issue that is likely to impact us and our healthcare system for decades.” said Dr. Mary Rojek, Director of Clinical Faculty Affairs and Development at SOMG. “While men have had a higher mortality rate from COVID, women are more likely to experience Long-COVID. COVID affects many body systems so that its long-term effects are still unknown. Dr. Singh has been a global leader on this issue, and we are eager to learn from her.”
Upinder Singh, MD, FIDSA, is a professor in the Departments of Internal Medicine and Microbiology and Immunology and Division Chief of Infectious Diseases and Geographic Medicine at the Stanford University School of Medicine. Dr. Singh is an international expert in infectious diseases. She is both a basic and a clinical scientist. Her basic science research focuses on the molecular and genomic applications of parasitic diseases, including Entamoeba histolytica and free-living amebae, and she has made many significant contributions to this field. Her clinical research has focused on COVID-19 and Long-COVID.
More about the Dr. E. Arthur Dreskin Distinguished Endowed Lecture Series at SOMG:
E. Arthur Dreskin, M.D., had a long and distinguished career in medicine and public service until his death in 2006. In memory of his outstanding leadership in South Carolina, his family has established the Dr. E. Arthur Dreskin Distinguished Endowed Lecture Series. The endowed lecture series brings nationally and internationally prominent speakers to address and consult with our school’s community on topics of high importance to health care and leadership. The lecture is presented annually.
